Redeye shares its initial take on Kontigo Care’s Q4 2024 results, which showed sales and monthly recurring revenue (MRR) in line with expectations. Key highlights include a resilient topline and MRR despite a challenging macro environment and an improved cash position that strengthens the company’s ability to drive business development and expand into new markets. Following the report, only minor forecast adjustments are expected.
LÄS MER